Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12624000959572p
Ethics application status
Not yet submitted
Date submitted
22/07/2024
Date registered
7/08/2024
Date last updated
7/08/2024
Date data sharing statement initially provided
7/08/2024
Type of registration
Prospectively registered
Titles & IDs
Public title
Urolithin A Supplementation on Physical Performance Change in Elite Academy Soccer Athletes Preseason
Query!
Scientific title
The Effects of Urolithin A Supplementation on Physical Performance Change in Elite Academy Soccer Athletes Preseason: A Randomised Pilot Trial
Query!
Secondary ID [1]
312577
0
None
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Oxidative stress
334590
0
Query!
Inflammation
334591
0
Query!
Condition category
Condition code
Musculoskeletal
331114
331114
0
0
Query!
Normal musculoskeletal and cartilage development and function
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Supplement containing Mitopure -
Sachet containing 1000 mg of Urolithin A (Mitopure) given once per day on each training occasion throughout the six week preseason period. Sachet given with at least 250 mL water dissolved in their usual protein drink supplement. This will be given and supervised by research staff and recorded on each occasion.
Query!
Intervention code [1]
329095
0
Treatment: Other
Query!
Comparator / control treatment
Placebo
isocaloric, cherry taste matched placebo control (Starburst Zero Sugar). Sachet given with at least 250 mL water dissolved in their usual protein drink supplement. This will be given and supervised by research staff and recorded on each occasion.
Sachet contains citric acid, maltodextrin, aspartame, malic acid, monocalcium phosphate, colours and flavours.
Query!
Control group
Placebo
Query!
Outcomes
Primary outcome [1]
338873
0
Change in field-based test of maximal aerobic capacity
Query!
Assessment method [1]
338873
0
YoYo Intermittent Recovery Test (IRT) 2 - meters covered.
Query!
Timepoint [1]
338873
0
Six weeks (baseline and six weeks post-baseline)
Query!
Secondary outcome [1]
437737
0
Urine oxidative stress (this will be composite outcome)
Query!
Assessment method [1]
437737
0
(i) free radical scavenging activity (ii) inhibition of free radical formation (iii) hydrogen peroxide scavenging activity (iv) lipid peroxide scavenging activity. All assays assess 4 different aspects of antioxidant activity. All assays were developed from the same fundamental platform in which the phenothiazine compound, 2,2'-azinobis-(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS), is oxidized to produce the radical cation (ABTS·+).
Query!
Timepoint [1]
437737
0
Six weeks (baseline and six weeks post-baseline)
Query!
Secondary outcome [2]
437738
0
Saliva oxidative stress (this will be composite outcome)
Query!
Assessment method [2]
437738
0
(i) free radical scavenging activity (ii) inhibition of free radical formation (iii) hydrogen peroxide scavenging activity (iv) lipid peroxide scavenging activity. All assays assess 4 different aspects of antioxidant activity. All assays were developed from the same fundamental platform in which the phenothiazine compound, 2,2'-azinobis-(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS), is oxidized to produce the radical cation (ABTS·+).
Query!
Timepoint [2]
437738
0
Six weeks (baseline and six weeks post-baseline)
Query!
Secondary outcome [3]
437739
0
the feasibility of UA supplementation
Query!
Assessment method [3]
437739
0
feasibility - drop out/retention rate based on audit of study per participant and per protocol records
Query!
Timepoint [3]
437739
0
Upon conclusion of the study
Query!
Secondary outcome [4]
437740
0
week-to-week changes in subjective stress and fatigue throughout the six-week preseason period
Query!
Assessment method [4]
437740
0
Short Recovery and Stress Scale (Kellman & Kölling, 2019) (this will be assessed as a composite outcome score)
Query!
Timepoint [4]
437740
0
Six weeks (weekly during the six week period)
Query!
Secondary outcome [5]
437752
0
Change in lower-limb strength production
Query!
Assessment method [5]
437752
0
Countermovement jump on dual force plate system (ForceDecks)
Query!
Timepoint [5]
437752
0
Six weeks (baseline and six weeks post-baseline)
Query!
Secondary outcome [6]
437753
0
Change in maximal sprint speed
Query!
Assessment method [6]
437753
0
Maximal sprint speed (timing gates - SmartSpeed).
Query!
Timepoint [6]
437753
0
Six weeks (baseline and six weeks post-baseline)
Query!
Secondary outcome [7]
437996
0
the acceptability of UA supplementation
Query!
Assessment method [7]
437996
0
survey designed for this study based on Sekhon et al., 2022
Query!
Timepoint [7]
437996
0
post-study (final visit at ~6 weeks post-baseline)
Query!
Secondary outcome [8]
437997
0
Change in lower-limb power production
Query!
Assessment method [8]
437997
0
Countermovement jump on dual force plate system (ForceDecks)
Query!
Timepoint [8]
437997
0
Six weeks (baseline and six weeks post-baseline)
Query!
Eligibility
Key inclusion criteria
We will be seeking players aged between 18-30 years of age (male), who train with the Central Coast Mariners National Premier League team throughout the preseason period (2024-2025). To participate, they must be actively training with, or planning to train with the Mariners throughout the 2024-2025 preseason period, and are required to be free of any medical conditions that may identify them to be at higher risk of injury or discomfort during the activities. Participants should have no pre-existing medical issues that may be worsened because of testing which is part of the research project. This will be determined by the relevant medical professionals within the department (e.g., doctor, physiotherapists). Players who are at higher risk of injury through participation would be flagged as such by the relevant medical professionals (e.g., doctor, physiotherapists) within the department and will not participate.
If a player withdraws from the training environment, or is unavailable for retesting at the end of the preseason period, that information and the reason for that (e.g., injury, signing with another team) will be recorded for descriptive purposes. Players will be given a three day window of availability at the beginning and end of the preseason to have their data recorded through the standard procedures if they are unavailable on the testing date.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
30
Years
Query!
Query!
Sex
Males
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
- Subjects with diagnosed medical conditions who are unable to participate in training throughout the six week preseason period
- Subjects who are unable to complete the training or testing protocols
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
The website Sealed Envelope (sealedenvelope.com) will be used for this purpose
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
The order of interventions will be determined through randomisation. The study will use block randomisation with the two conditions (placebo control and supplementation) and block sizes of four. Participants will be randomised and then allocated to the two conditions on a 1:1 basis.
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
1/10/2024
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
20
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
NSW
Query!
Funding & Sponsors
Funding source category [1]
316974
0
Commercial sector/Industry
Query!
Name [1]
316974
0
Central Coast Mariners Football Club
Query!
Address [1]
316974
0
Query!
Country [1]
316974
0
Australia
Query!
Primary sponsor type
University
Query!
Name
University of Newcastle
Query!
Address
Query!
Country
Australia
Query!
Secondary sponsor category [1]
319253
0
None
Query!
Name [1]
319253
0
None
Query!
Address [1]
319253
0
Query!
Country [1]
319253
0
Query!
Ethics approval
Ethics application status
Not yet submitted
Query!
Ethics committee name [1]
315729
0
The University of Newcastle Human Research Ethics Committee
Query!
Ethics committee address [1]
315729
0
http://www.newcastle.edu.au/research/research-services/human-ethics/
Query!
Ethics committee country [1]
315729
0
Australia
Query!
Date submitted for ethics approval [1]
315729
0
12/08/2024
Query!
Approval date [1]
315729
0
Query!
Ethics approval number [1]
315729
0
Query!
Summary
Brief summary
This is a randomised, blinded, placebo-controlled pilot study examining the effect of Urolithin A (UA) supplementation on 18 - 30 year old elite academy soccer players preseason training adapations through a six week preseason. UA (as Mitopure) will be given once per day on each training occasion throughout the six week preseason and training adaptations will be assessed through changes in aerobic capacity (YoYo IRT2), strength and power, and maximal sprint speed. Urine and saliva will be analysed for changes in oxidative stress across the six weeks, and perceived stress will be captured weekly throughout the six week preseason period. It is hypothesised that UA will assist players in developing training adaptations such as strength, power, and aerobic fitness throughout the preseason period.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
135622
0
Dr Mitchell Naughton
Query!
Address
135622
0
EXSB204 UoN Ourimbah Campus - 10 Chittaway Rd, Ourimbah NSW 2258
Query!
Country
135622
0
Australia
Query!
Phone
135622
0
+61 413288621
Query!
Fax
135622
0
Query!
Email
135622
0
[email protected]
Query!
Contact person for public queries
Name
135623
0
Mitchell Naughton
Query!
Address
135623
0
EXSB204 UoN Ourimbah Campus - 10 Chittaway Rd, Ourimbah NSW 2258
Query!
Country
135623
0
Australia
Query!
Phone
135623
0
+61 413288621
Query!
Fax
135623
0
Query!
Email
135623
0
[email protected]
Query!
Contact person for scientific queries
Name
135624
0
Mitchell Naughton
Query!
Address
135624
0
EXSB204 UoN Ourimbah Campus - 10 Chittaway Rd, Ourimbah NSW 2258
Query!
Country
135624
0
Australia
Query!
Phone
135624
0
+61 413288621
Query!
Fax
135624
0
Query!
Email
135624
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF